Literature DB >> 18573311

Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.

A K Marr1, H Jenssen, M Roshan Moniri, R E W Hancock, N Panté.   

Abstract

Although both lactoferrin (Lf), a component of the innate immune system of living organisms, and its N-terminal pepsin cleavage product lactoferricin (Lfcin) have anti-herpes activity, the precise mechanisms by which Lf and Lfcin bring about inhibition of herpes infections are not fully understood. In the present study, experiments were carried out to characterize the activity of bovine Lf and Lfcin (BLf and BLfcin) against the Herpes simplex virus-1 (HSV-1). HSV-1 cellular uptake and intracellular trafficking were studied by immunofluorescence microscopy. In comparison to the untreated infected control cells, both the BLf- and BLfcin-treated cells showed a significant reduction in HSV-1 cellular uptake. The few virus particles that were internalized appeared to have a delayed intracellular trafficking. Thus, in addition to their interference with the uptake of the virus into host cells, Lf and Lfcin also exert their antiviral effect intracellularly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573311     DOI: 10.1016/j.biochi.2008.05.016

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  16 in total

Review 1.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

2.  Therapeutic approaches using host defence peptides to tackle herpes virus infections.

Authors:  Håvard Jenssen
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

3.  In silico investigation of lactoferrin protein characterizations for the prediction of anti-microbial properties.

Authors:  Seyyed Mohsen Sohrabi; Ali Niazi; Mahmood Chahardoli; Ali Hortamani; Payam Setoodeh
Journal:  Mol Biol Res Commun       Date:  2014-06

Review 4.  Antiviral properties of lactoferrin--a natural immunity molecule.

Authors:  Francesca Berlutti; Fabrizio Pantanella; Tiziana Natalizi; Alessandra Frioni; Rosalba Paesano; Antonella Polimeni; Piera Valenti
Journal:  Molecules       Date:  2011-08-16       Impact factor: 4.411

Review 5.  Lactoferrin a multiple bioactive protein: an overview.

Authors:  Isui Abril García-Montoya; Tania Siqueiros Cendón; Sigifredo Arévalo-Gallegos; Quintín Rascón-Cruz
Journal:  Biochim Biophys Acta       Date:  2011-06-25

Review 6.  Antiviral peptides as promising therapeutic drugs.

Authors:  Liana Costa Pereira Vilas Boas; Marcelo Lattarulo Campos; Rhayfa Lorrayne Araujo Berlanda; Natan de Carvalho Neves; Octávio Luiz Franco
Journal:  Cell Mol Life Sci       Date:  2019-05-17       Impact factor: 9.261

Review 7.  Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.

Authors:  Tolulope Joshua Ashaolu; Asad Nawaz; Noman Walayat; Ibrahim Khalifa
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-19       Impact factor: 4.813

Review 8.  Human Antimicrobial Peptides as Therapeutics for Viral Infections.

Authors:  Aslaa Ahmed; Gavriella Siman-Tov; Grant Hall; Nishank Bhalla; Aarthi Narayanan
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048

Review 9.  Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections.

Authors:  Aldo Vagge; Carlotta Senni; Federico Bernabei; Marco Pellegrini; Vincenzo Scorcia; Carlo E Traverso; Giuseppe Giannaccare
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

10.  The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor.

Authors:  Yanmei Hu; Xiangzhi Meng; Fushun Zhang; Yan Xiang; Jun Wang
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.